The Efficacy Of Green Light Therapy Treatment for Migraines

Abstract

Migraines affect over a billion people worldwide and are characterized by acute head pain, light sensitivity, and sometimes nausea. As migraines can be very debilitating, many pharmaceutical treatment options are available. However, for some people, these treatments may be ineffective and inconvenient. This study seeks to explore the underlying physiological mechanisms underlying Green Light Diode therapy and its connection to oculomotor control and neuron activation. Employing a completely randomized double-blind crossover experimental design allows researchers to examine the effects of GLED exposure daily, over a period of 14 days. Near-Infrared Spectroscopy, Electroencephalography, and Right Eye system's eye-tracking technology, are all employed to detect changes in blood flow, pressure, and electrical activity through alpha waves. Previous data collected within our laboratory indicated that those suffering from migraines, when compared directly to healthy controls, tend to express decreased blood flow within the temporal lobes and impaired oculomotor control. We hypothesize that the introduction of GLED therapy to chronic and episodic migraine sufferers will assist in correcting deficits in blood flow and effectively lower migraine frequency as a whole. This study aims to support a safe and non-invasive treatment of migraines while explaining the mechanism of photo biomodulation within the human brain.